Omar Benitez
General Practice · Miami, FLNPI 1912170556
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $324 of the $474 with a category attached, or 68.3%. AbbVie accounts for 64.1% of it on its own, with 2 other manufacturers making up the rest.
Across 7 payments — averaging $67.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$304
- Galderma Laboratories, L.p.$150
- Kowa Pharmaceuticals America, Inc.$20
Across 2,952 payments — averaging $2342.81 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Modernatx, Inc.$4.3M
- Pfizer$2M
- Taro Pharmaceuticals USA, Inc.$208K
- AbbVie$142K
- Evofem Biosciences, Inc.$138K
- Ferring International Pharmascience Center US$33K
- plus $93K from 6 others
What the payments were for
- Speaking & faculty fees$15032%
- Food & beverage$32468%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 5 | $304 |
| Galderma Laboratories, L.p. | 1 | $150 |
| Kowa Pharmaceuticals America, Inc. | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BOTOX$107
How this compares
$474 in reported general payments places this provider in the 65th percentile of 6,901 general practice providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 18 | $16,665 |
| Tadalafil | 12 | $2,218 |
| Lansoprazole | 11 | $306 |
| Diclofenac Sodium | 34 | $254 |
| Ketoconazole | 15 | $252 |
| Gabapentin | 33 | $191 |
| Repaglinide | 11 | $173 |
| Triamcinolone Acetonide | 13 | $165 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 24 | $156 |
| Metoprolol Succinate | 16 | $148 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 11 | $139 |
| Levothyroxine Sodium | 12 | $131 |
| Lactulose | 15 | $131 |
| Omeprazole | 26 | $116 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 19 | $108 |
Paid to pharmacies, not to this prescriber.
Other general practice in Miami
- Idalia AcostaMiami$99K
- Eddie GomezMiami$59K
- Aladino ValienteMiami$24K
- Viviana WaichMiami$20K
- Libia RiosMiami$15K
- Jose CardonaMiami$15K
- Rosa HuguetMiami$15K
- Robert VogelPalm Beach Gardens$1M
- Bruce OuelletteWest Palm Beach$724K
- Caley CasteleinMiami Beach$586K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.